Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

On Sept 26, Frequency Therapeutics Gave Notice To Oppenheimer Of Termination Of Sales Deal Pursuant To Section 11(B) Thereof, Effective Immediately; Is Not Subject To Any Termination Penalties Related To Termination Of Sales Agreement

Author: Benzinga Newsdesk | September 27, 2023 04:12pm

- SEC Filing

Posted In: FREQ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist